MORU Profile
MORU

@MORUBKK

Followers
4K
Following
700
Media
605
Statuses
3K

Mahidol Oxford Tropical Medicine Research Unit. We conduct research on infectious tropical diseases including malaria, meliodosis, leptospirosis and typhus

Bangkok, Thailand
Joined September 2014
Don't wanna be here? Send us removal request.
@MORUBKK
MORU
1 day
“I came for 6 months to the Thai–Myanmar border & it’s been more than 30 years, thanks to the incredibly brave Karen and Burmese women.” Well done, Rose McGready, what a difference you've made to countless mothers and babies! https://t.co/0GTzfRiDtx @shokloun @wellcometrust
Tweet card summary image
tropmedres.ac
On 17 Nov at a ceremony in Canberra, Prof Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), was honoured with the 2026 ACT Australian of the Year Award for her extraordinary...
0
3
3
@MORUBKK
MORU
9 days
Every year, millions of deaths in LMICs go unregistered or with no reliable data on causes of death. What were the most significant causes of death in SE Asia found by this @wellcometrust-funded verbal autopsy @LancetGH study? https://t.co/9HWzbu1nFC
0
4
2
@MORUBKK
MORU
18 days
Faulty field test undermines fight against malaria, says new @shokloun & MOCRU research in @MalariaJournal Abbott-Bioline RDTs in use across Asia and South America seem to give false negative results https://t.co/mSqNzNlYR1 @sneweyy @NDMOxford @TropMedOxford @wellcometrust
Tweet card summary image
telegraph.co.uk
The suspect devices are in use across vast swathes of Asia and South America and appear to throwing false negative results
0
5
2
@MORUBKK
MORU
18 days
1st large-scale genomic exploration of H influenzae, which causes 200m infections/yr in kids, reveals extensive antibiotic resistance #AMR, uncovers genetic clues that could lead to future vaccine @NatureMicrobiol: https://t.co/gjqGAv3DP0 @sangerinstitute: https://t.co/Qn5gQxOW21
0
2
1
@MORUBKK
MORU
22 days
TB heavily hits LMICs w gold standard molecular diagnostic assays ~Xpert MTB/RIF oft not avail @wellcometrust funded @PLOSGPH study finds tongue swab samples novel rapid molecular diagnostic test nLRDT a cost-effective diagnostic tool in rural Philippines https://t.co/8CYGOQQOI3
0
4
3
@MORUBKK
MORU
23 days
ACORN2 study in @GlobalHealthBMJ confirms a low blood culture BC yield in hospitalised kids in LMICs (4.5%) with a 2x higher contamination rate (9%). For which groups s/d LMIC healthcare workers develop protocols to optimise BC uptake in hospitalised kids? https://t.co/XmEA6mcobc
0
4
3
@MORUBKK
MORU
23 days
This important future pandemic preparation work funded by @wellcometrust through the COVID-19 Therapeutics Accelerator. See original paper @TheLancetInfDis:
Tweet card summary image
thelancet.com
Both ensitrelvir and nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance. Ensitrelvir is an effective alternative to currently available antivirals in treating COVID-19. Although...
@TropMedOxford
Tropical Medicine Oxford
25 days
New data show Ensitrelvir (an oral antiviral) exhibits strong activity against #COVID19 in a first head-to-head study with Paxlovid, offering promise for effective and well-tolerated alternative treatment options @MORUBKK Read more 👉
0
4
5
@TropMedOxford
Tropical Medicine Oxford
24 days
#ResearchHighlight from Vanheuang Phommadeechack @MORUBKK Identification and pathogen screening of ectoparasites from companion animals in urban Vientiane, Lao PDR Read more 👉 https://t.co/jmlRXQpbC4 Full publication 👉 https://t.co/fDow12XFNc
0
2
1
@MORUBKK
MORU
1 month
Melioidosis, a tropical infection caused by the soil bacterium B pseudomallei results in est'd 165 000 cases & 89 000 deaths ea yr, yet is a disease so neglected it's NOT on WHO's list of Neglected Tropical Diseases (NTDs). Why isn't it classed as an NTD? https://t.co/ZrJqFEuu7m
1
10
19
@MORUBKK
MORU
1 month
FD-TACT's trial of artemether-lumefantrine & amodiaquine ALAQ comes as artemisinin resistance threatens #malaria control in Africa, w/estimates that widespread resistance could lead to 16m add'l malaria cases & 360,000 hospitalized severe cases annually.
Tweet card summary image
tropmedres.ac
A Phase 3 pivotal trial, led by MORU and funded by Japan’s Global Health Innovative Technology Fund (GHIT), has begun to evaluate a novel fixed-dose triple artemisinin-based combination treatment...
@TropMedOxford
Tropical Medicine Oxford
1 month
FD-TACT malaria treatment trial launches patient recruitment in Rwanda Led by @MORUBKK, this trial aims to evaluate a novel triple artemisinin-based combination treatment for uncomplicated Plasmodium falciparum #malaria Read more 👉 https://t.co/6KkKwRx2vv 📷 Mehul Dhorda, MORU
0
4
4
@MORUBKK
MORU
2 months
In Asia’s first mass rollout of the R21 #malaria vaccine, @MORUBKK scientists travel by motorbike, boat & foot, analysing whether the shot could accelerate the push to elimination in #Bangladesh. Here's the deal: https://t.co/PVR1mBKkBL
0
10
8
@TropMedOxford
Tropical Medicine Oxford
2 months
@Joel_Tarning @MORUBKK awarded @RSTMH 2025 Chalmers Medal Joel has been honoured for his exceptional contribution to the field of clinical pharmacology of neglected tropical diseases, and in particular antimalarial therapy. Read more 👉 https://t.co/4QYay6BKIN
1
4
3
@APMEN
Asia Pacific Malaria Elimination Network
3 months
Last month, #APMEN Border Malaria SIG, hosted by @MORUBKK, convened a landmark Peer-to-Peer Exchange on Cross-Border Malaria Surveillance and Response between #Indonesia and #Malaysia. 🔗 Find out more about the key outcomes of this convening: https://t.co/JYKIArcUBx
0
3
4
@KEMRI_Wellcome
KEMRI-Wellcome
2 months
Great start to the #OTN2025 in #Mombasa with pre-conference sessions! To start us off, was the @wellcometrust, Africa Asia Programmes Acceleration of Genomics for Escalating Infectious Diseases-CAGED project kick off meeting. Bringing together colleagues from 11 countries across
0
9
36
@MORUBKK
MORU
3 months
Which host biomarkers can best ID children with an acute febrile illness who are at risk of severe outcomes? SPOT SEPSIS study in @LancetChildAdol finds that soluble TREM1 [sTREM1] showed best prognostic accuracy - outperforming WHO danger signs! https://t.co/u9v60X422R @MSF
0
4
7
@MORUBKK
MORU
3 months
Simple new method that measures viral clearance means promising antibody treatments for #Covid & flu can be quickly assessed for effectiveness, say researchers in @TheLancet, & save time, money, lives in next pandemic https://t.co/PxN74Lv0ni Full paper: https://t.co/k1MKnznLLm
0
7
8
@IDDOnews
IDDO @iddonews.bsky.social
4 months
Have you watched the latest @cerclecoalition lecture? Prof. Phaik Yeong Cheah of @MORUBKK shares hard-won insights from the Thai-Myanmar border on ethics, engagement and power in global health. Watch here: https://t.co/3TKi9m2FuJ
0
6
5
@MORUBKK
MORU
4 months
Testing for life-threatening glucose-6-phsophate dehydrogenase G6PD deficiency is recommended before using 8-aminoquinolines for radical cure of P vivax #malaria. Wondfo G6PD/Hb Test shows good diagnostic performance using current manufacturer thresholds https://t.co/jeSHqmoYPI
@TropMedOxford
Tropical Medicine Oxford
4 months
#ResearchHighlight from Germana Bancone, SMRU @MORUBKK Evaluation of the Wondfo G6PD/Hb Test for glucose-6-phosphate dehydrogenase deficiency: preliminary performance, matrix equivalence, and usability 👉 https://t.co/jmlRXQpbC4 Full publication 👉 https://t.co/KWaILt2O4h
0
2
3
@MORUBKK
MORU
5 months
New @BioMedCentral paper presents first evidence-based regimens of single low dose primaquine SLDPQ, offering flexible options for malaria elimination. The case for 3.75 mg is compelling @WHO needs to urgently consider reinstating it. Here's why: https://t.co/vG4aCYZCUz
0
3
2